ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 187,65
0,00%
Dow Jones
39 387,76
0,85%
DAX
18 686,60
1,07%
Brent Oil
84,275
0,39%
Bitcoin
62 880,57
-0,27%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Transkaryotic Therapies (MM) (TKTX)

  7. Transkaryotic Therapies (MM) (TKTX) Actualités

TKTX

Transkaryotic Therapies (TKTX)

Transkaryotic Therapies (MM)
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:TKTX
DateHeureSourceTitreSymboleSociété
26/02/202022h05GlobeNewswire Inc.CRISPR Therapeutics Proposes Changes to the Board of DirectorsNASDAQ:TKTXTranskaryotic Therapies (MM)
27/07/200517h36PR Newswire (US)TKT Stockholders Approve Acquisition by ShireNASDAQ:TKTXTranskaryotic Therapies (MM)
15/07/200500h22PR Newswire (US)TKT Confirms That Board of Directors Unanimously Recommends That Stockholders Approve Shire TransactionNASDAQ:TKTXTranskaryotic Therapies (MM)
12/07/200515h01PR Newswire (US)TKT Issues Open Letter to StockholdersNASDAQ:TKTXTranskaryotic Therapies (MM)
27/06/200520h14PR Newswire (US)TKT to Hold Special Meeting of Stockholders on July 27, 2005NASDAQ:TKTXTranskaryotic Therapies (MM)
20/06/200515h01PR Newswire (US)TKT Reports Positive Top-Line Results of Hunter Syndrome Pivotal TrialNASDAQ:TKTXTranskaryotic Therapies (MM)
13/06/200515h41PR Newswire (US)TKT Announces Expiration of Both Hart-Scott-Rodino Waiting Period and SEC Review Period of Preliminary Proxy StatementNASDAQ:TKTXTranskaryotic Therapies (MM)
05/05/200515h00PR Newswire (US)TKT Announces First Quarter 2005 ResultsNASDAQ:TKTXTranskaryotic Therapies (MM)
28/04/200501h23PR Newswire (US)TKT Assessing Impact of Fire at Manufacturing FacilityNASDAQ:TKTXTranskaryotic Therapies (MM)
27/04/200523h30PR Newswire (US)TKT to Report First Quarter 2005 Financial Results on May 5, 2005NASDAQ:TKTXTranskaryotic Therapies (MM)
21/04/200516h50PR Newswire (US)TKT Announces Agreement to be Acquired by Shire for $1.6 BillionNASDAQ:TKTXTranskaryotic Therapies (MM)
20/04/200516h43PR Newswire (US)TKT Achieves GA-GCB Clinical MilestoneNASDAQ:TKTXTranskaryotic Therapies (MM)
29/03/200522h23PR Newswire (US)TKT Announces Appointment of Eric Pauwels as Senior Vice President, Global Commercial OperationsNASDAQ:TKTXTranskaryotic Therapies (MM)
29/03/200500h04PR Newswire (US)New Website Offers Comprehensive Information on Hunter SyndromeNASDAQ:TKTXTranskaryotic Therapies (MM)
24/03/200515h30PR Newswire (US)TKT to Present at Two Upcoming Healthcare ConferencesNASDAQ:TKTXTranskaryotic Therapies (MM)
17/03/200514h01PR Newswire (US)Notice to All Deutsche Bank Securities Inc. Clients From the Securities Arbitration Law Firm of Klayman & Toskes, P.A.NASDAQ:TKTXTranskaryotic Therapies (MM)
09/03/200520h21PR Newswire (US)TKT to Present at SG Cowen Securities' 25th Annual HealthCare ConferenceNASDAQ:TKTXTranskaryotic Therapies (MM)
23/02/200514h00PR Newswire (US)Strong Year of Execution Produces Solid 2004 Financial PerformanceNASDAQ:TKTXTranskaryotic Therapies (MM)
15/02/200515h31PR Newswire (US)Tamara L. Joseph Named General Counsel of TKTNASDAQ:TKTXTranskaryotic Therapies (MM)
10/02/200515h17PR Newswire (US)TKT to Report Fourth Quarter and Year-End 2004 Financial Results on February 23, 2005NASDAQ:TKTXTranskaryotic Therapies (MM)
04/02/200515h15PR Newswire (US)TKT Appoints Theresa Heggie as General Manager, EuropeNASDAQ:TKTXTranskaryotic Therapies (MM)
24/01/200521h59PR Newswire (US)Genzyme Sues to Halt TKT Gaucher TrialNASDAQ:TKTXTranskaryotic Therapies (MM)
11/01/200522h01PR Newswire (US)TKT Provides Update on Product Pipeline at JPMorgan Healthcare ConferenceNASDAQ:TKTXTranskaryotic Therapies (MM)
04/01/200516h02PR Newswire (US)TKT to Present at JPMorgan's Annual HealthCare ConferenceNASDAQ:TKTXTranskaryotic Therapies (MM)
09/12/200417h23PR Newswire (US)TKT to Present at Wachovia Biotechnology ConferenceNASDAQ:TKTXTranskaryotic Therapies (MM)
12/11/200415h15PR Newswire (US)TKT Announces Executive PromotionsNASDAQ:TKTXTranskaryotic Therapies (MM)
09/11/200414h35PR Newswire (US)TKT to Present At SG Cowen's Fifth Annual Global Health Care ConferenceNASDAQ:TKTXTranskaryotic Therapies (MM)
09/11/200414h30PR Newswire (US)TKT Reports Third Quarter 2004 Financial ResultsNASDAQ:TKTXTranskaryotic Therapies (MM)
29/10/200422h58PR Newswire (US)TKT To Report Third Quarter Financial Results On November 9, 2004NASDAQ:TKTXTranskaryotic Therapies (MM)
29/10/200400h01PR Newswire (US)TKT's Research Findings on Intrathecal Delivery of I2S Presented at ASHGNASDAQ:TKTXTranskaryotic Therapies (MM)
 Showing the most relevant articles for your search:NASDAQ:TKTX

Dernières Valeurs Consultées

EU
BEL20
Bel 20
EU
SGO
Cie de SaintGobain
EU
RI
Pernod Ricard
EU
HO
Thales
EU
AI
Air Liquide
NASDAQ
NVDA
NVIDIA
EU
LR
Legrand
EU
BNP
BNP Paribas
NASDAQ
AMZN
Amazon.com
EU
PX4
SBF 120
EU
VIV
Vivendi
FTSE
UKX
FTSE 100
EU
RNO
Renault
COIN
BTCUSD
Bitcoin
EU
VK
Vallourec
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés